Literature DB >> 2825542

Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution.

D A Bushinsky1, R J Lechleider.   

Abstract

Protons are buffered and calcium is released by bone during metabolic acidosis. Incubation of neonatal mouse calvariae in acid medium causes net calcium efflux from bone and net proton influx into bone, just as metabolic acidosis does in vivo. To determine whether the calcium carbonate phase of bone mineral is solubilized with increasing proton concentrations, we cultured calvariae for 3 h in medium in which the saturation was varied by changing pH or calcium and phosphate concentrations. We determined the driving force for crystallization by calculating the Gibbs free energy of formation (DG). With alteration of the medium pH, calcium carbonate entry or loss from bone varied linearly with the initial DG for medium calcium carbonate (r = -0.745, n = 41, P less than 0.001) as it did with alteration of the medium calcium and phosphate (r = -0.665, n = 118, P less than 0.001). There was dissolution of calcium carbonate into medium that was unsaturated with respect to calcium carbonate, net flux ceased at saturation, and calcium carbonate entered bone from supersaturated medium, indicating that the medium is in equilibrium with the calcium carbonate phase of bone mineral. Neither the mineral phase brushite nor apatite was in equilibrium with the medium. These observations indicate that in vitro, acute proton-induced calcium efflux is due to dissolution of bone calcium carbonate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825542     DOI: 10.1152/ajprenal.1987.253.5.F998

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone.

Authors:  Nancy S Krieger; Christopher D Culbertson; Kelly Kyker-Snowman; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

2.  Effect of metabolic and respiratory acidosis on intracellular calcium in osteoblasts.

Authors:  Kevin K Frick; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

Review 3.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 4.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Effects of acid on bone.

Authors:  David A Bushinsky; Nancy S Krieger
Journal:  Kidney Int       Date:  2022-03-26       Impact factor: 18.998

6.  1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Nancy S Krieger; Christopher D Culbertson; Daniel M Asplin; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-07

Review 7.  Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality.

Authors:  Tanis R Fenton; Suzanne C Tough; Andrew W Lyon; Misha Eliasziw; David A Hanley
Journal:  Nutr J       Date:  2011-04-30       Impact factor: 3.271

Review 8.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.